Answer
According to the two-compartmental model, bevacizumab’s elimination half-life is 18 days in a typical female patient and 20 days in a typical male patient.
Sources for this answer
- Avastin 25mg/ml concentrate for solution for infusionRoche Products Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 64Document updated
Sources checked